Fecal microbiota transplant (FMT) of JAX mice (via oral gavage) to TAC recipients was sufficient to augment CD8+ T cell infiltration into tumor, and slow the melanoma growth rate to the same extent as treatment with an anti-programmed-death-ligand-1 antibody (anti-PD-1 Ab). The gene discussed is CD8A; the disease is neoplasm.